902 KAR 55:025. Schedule III substances.

 

RELATES TO: KRS 218A.010-218A.030, 218A.080, 218A.090, 21 C.F.R. 1308.13, 21 U.S.C. 801, 812

STATUTORY AUTHORITY: KRS 218A.020

NECESSITY, FUNCTION, AND CONFORMITY: KRS 218A.020 authorizes the Cabinet for Health Services to add, delete, or reschedule substances enumerated in KRS Chapter 218A. This administrative regulation designates Schedule III controlled substances.

 

Section 1. Amphetamine and Methamphetamine Combination Products. The Cabinet for Health Services designates the following amphetamine and methamphetamine combination products as Schedule III Controlled Substances:

(1) A tablet or capsule containing:

(a) Methamphetamine hydrochloride 1 mg.;

(b) Conjugated estrogens-equine 0.25 mg.; and

(c) Methyl testosterone 2.5 mg; and

(2) A liquid containing, in each 15 cc:

(a) Methamphetamine hydrochloride 1 mg.;

(b) Conjugated estrogens-equine 0.25 mg.; and

(c) Methyl testosterone 2.5 mg.

 

Section 2. Stimulants. The Cabinet for Health Services designates as Schedule III controlled substances a material, compound, mixture, or preparation which contains any quantity of the following substances having a stimulant effect on the central nervous system, including their salts, isomers (whether optical position or geometric), and salts of those isomers if the existence of the salts, isomers or salts of isomers is possible within the specific chemical designation:

(1) Benzphetamine;

(2) Chlorphentermine;

(3) Chlortermine; and

(4) Phendimetrazine.

 

Section 3. Depressants. The Cabinet for Health Services designates as Schedule III controlled substances the following:

(1) A material, compound, mixture, or preparation containing amobarbital, secobarbital, or pentobarbital, or any of their salts, and at least one (1) other active medicinal ingredient which is not a controlled substance;

(2) A suppository dosage form containing amobarbital, secobarbital, or pentobarbital, or any of their salts, which has been approved by the United States Food and Drug Administration for marketing only as a suppository;

(3) A drug product containing gamma-hydroxybutyric acid, including its salts, isomers, and salts of isomers, for which an application is approved under section 505 of the Federal Food, Drug, and Cosmetic Act, 21 USC Chapter 9. Gamma hydroxybutyric acid is also known as:

(a) GHB;

(b) Gamma-hydroxybutyrate;

(c) 4-hydroxybutyrate;

(d) 4-hydroxybutanoic acid;

(e) Sodium oxybate; or

(f) Sodium oxybutyrate;

(4) Ketamine, its salts, isomers, and salts of isomers. Ketamine is also known as ()-2-(2-chlorophenyl)-2-(methylamino)-cyclhexanone; and

(5) Tiletamine and zolazepam or any of their salts.

(a) Tiletamine is also known as 2-(ethylamino)-2-(2-thienyl)-cyclohexanone.

(b) Zolazepam is also known as 4-(2-fluorophenyl)-6,8-dihydro-1,3,8-trimethylpyrazolo-(3,4-e) (1,4)-dizepin-7(1H)one, flupyrazpon.

 

Section 4. Pentazocine Drug Products. The Cabinet for Health Services designates, in addition to the parenteral or injectable form of Pentazocine which is designated as a Schedule III controlled substance by KRS 218A.090(3), a material, compound, mixture, or preparation which contains a quantity of Pentazocine, including its salts.

 

Section 5. Anabolic Steroids. The Cabinet for Health Services designates as Schedule III Controlled Substances, in addition to those listed in KRS 218.090(5), a material, compound, mixture, or preparation which contains a quantity of the following substances, including its salts, isomers, and salts of isomers, if the existence of salts of isomers is possible within the specific chemical designation:

(1) Chlorotestosterone;

(2) Dihydrotestosterone; and

(3) Methandranone.

 

Section 6. Hallucinogenic Substances. The Cabinet for Health Services designates as Schedule III controlled substances, in addition to those listed in KRS 218A.090, a material, compound, mixture, or preparation which contains a quantity of dronabinol (synthetic) in sesame oil and encapsulated in a soft gelatin capsule in a U.S. Food and Drug Administration approved product. Dronabinol is also known as:

(1) (6aR-trans)-6a, 7, 8, 10a- tetrahydro-6, 6, 9-trimethyl-3-pentyl-6H-dibenzo{b,d}pyran-1-ol; or

(2) (-)- delta-9-(trans)- tetrahydrocannabinol.

 

Section 7. Narcotics. The Cabinet for Health Services designates as Schedule III controlled substance a material, compound, mixture, or preparation which contains any quantity of buprenorphine, or its salts. (Recodified from 901 KAR 1:025, 4-14-82; Am. 11 Ky.R. 1676; eff. 6-4-85; 13 Ky.R. 1946; eff. 6-9-87; 15 Ky.R. 865; eff. 11-4-88; 17 Ky.R. 3283; eff. 6-19-91; 20 Ky.R. 861; eff. 12-6-93; 26 Ky.R. 1238; 1562; eff. 2-1-2000; 29 Ky.R. 817; 1277; eff. 10-16-02.)